# Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)

> **NCT00190541** · PHASE3 · COMPLETED · sponsor: **Haruhiko Fukuda** · enrollment: 700 (actual)

## Conditions studied

- Rectal Neoplasms

## Interventions

- **PROCEDURE:** Mesorectal excision with lateral lymph node dissection
- **PROCEDURE:** Mesorectal excision without lateral lymph node excision

## Key facts

- **NCT ID:** NCT00190541
- **Lead sponsor:** Haruhiko Fukuda
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 700 (ACTUAL)
- **Last updated:** 2016-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00190541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00190541, "Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00190541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*